138 related articles for article (PubMed ID: 10862500)
1. Lesioning of locus coeruleus projections by DSP-4 neurotoxin treatment: effect on amphetamine-induced hyperlocomotion and dopamine D2 receptor binding in rats.
Harro J; Meriküla A; Lepiku M; Modiri AR; Rinken A; Oreland L
Pharmacol Toxicol; 2000 May; 86(5):197-202. PubMed ID: 10862500
[TBL] [Abstract][Full Text] [Related]
2. Effects of low dose N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine administration on exploratory and amphetamine-induced behavior and dopamine D2 receptor function in rats with high or low exploratory activity.
Alttoa A; Kõiv K; Eller M; Uustare A; Rinken A; Harro J
Neuroscience; 2005; 132(4):979-90. PubMed ID: 15857703
[TBL] [Abstract][Full Text] [Related]
3. Amphetamine-induced locomotion, behavioral sensitization to amphetamine, and striatal D2 receptor function in rats with high or low spontaneous exploratory activity: differences in the role of locus coeruleus.
Alttoa A; Eller M; Herm L; Rinken A; Harro J
Brain Res; 2007 Feb; 1131(1):138-48. PubMed ID: 17156751
[TBL] [Abstract][Full Text] [Related]
4. Effect of denervation of the locus coeruleus projections by DSP-4 treatment on [3H]-raclopride binding to dopamine D(2) receptors and D(2) receptor-G protein interaction in the rat striatum.
Harro J; Terasmaa A; Eller M; Rinken A
Brain Res; 2003 Jun; 976(2):209-16. PubMed ID: 12763255
[TBL] [Abstract][Full Text] [Related]
5. The effect of denervation of the locus coeruleus projections with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) on cocaine-induced locomotion and place preference in rats.
Kõiv K; Zobel R; Raudkivi K; Kivastik T; Harro J
Behav Brain Res; 2011 Jan; 216(1):172-9. PubMed ID: 20678524
[TBL] [Abstract][Full Text] [Related]
6. Functional recovery of locus coeruleus noradrenergic neurons after DSP-4 lesion: effects on dopamine levels and neuroleptic induced-parkinsonian symptoms in rats.
Srinivasan J; Schmidt WJ
J Neural Transm (Vienna); 2004 Jan; 111(1):13-26. PubMed ID: 14714212
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals.
Fritschy JM; Grzanna R
Neuroscience; 1989; 30(1):181-97. PubMed ID: 2747911
[TBL] [Abstract][Full Text] [Related]
8. Effects of partial locus coeruleus denervation and chronic mild stress on behaviour and monoamine neurochemistry in the rat.
Häidkind R; Eller M; Harro M; Kask A; Rinken A; Oreland L; Harro J
Eur Neuropsychopharmacol; 2003 Jan; 13(1):19-28. PubMed ID: 12480118
[TBL] [Abstract][Full Text] [Related]
9. Novelty-oriented behavior in the rat after selective damage of locus coeruleus projections by DSP-4, a new noradrenergic neurotoxin.
Delini-Stula A; Mogilnicka E; Hunn C; Dooley DJ
Pharmacol Biochem Behav; 1984 Apr; 20(4):613-8. PubMed ID: 6728877
[TBL] [Abstract][Full Text] [Related]
10. Partial denervation of the locus coeruleus projections by treatment with the selective neurotoxin DSP-4 potentiates the long-term effect of parachloroamphetamine on 5-hydroxytryptamine metabolism in the rat.
Eller M; Harro J
Neurosci Lett; 2002 Mar; 322(1):53-6. PubMed ID: 11958842
[TBL] [Abstract][Full Text] [Related]
11. Chronic mild unpredictable stress after noradrenergic denervation: attenuation of behavioural and biochemical effects of DSP-4 treatment.
Harro J; Häidkind R; Harro M; Modiri AR; Gillberg PG; Pähkla R; Matto V; Oreland L
Eur Neuropsychopharmacol; 1999 Dec; 10(1):5-16. PubMed ID: 10647090
[TBL] [Abstract][Full Text] [Related]
12. Changes in cholecystokinin receptor binding in rat brain after selective damage of locus coeruleus projections by DSP-4 treatment.
Harro J; Jossan SS; Oreland L
Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):425-31. PubMed ID: 1436127
[TBL] [Abstract][Full Text] [Related]
13. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
Srinivasan J; Schmidt WJ
Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435
[TBL] [Abstract][Full Text] [Related]
14. Denervation of the locus coeruleus projections by treatment with the selective neurotoxin DSP-4 [N (2-chloroethyl)-N-ethyl-2-bromobenzylamine] reduces dopamine release potential in the nucleus accumbens shell in conscious rats.
Häidkind R; Kivastik T; Eller M; Kolts I; Oreland L; Harro J
Neurosci Lett; 2002 Oct; 332(2):79-82. PubMed ID: 12384215
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y attenuates the effect of locus coeruleus denervation by DSP-4 treatment on social behaviour in the rat.
Kask A; Eller M; Oreland L; Harro J
Neuropeptides; 2000 Feb; 34(1):58-61. PubMed ID: 10688970
[TBL] [Abstract][Full Text] [Related]
16. Evidence that 3,3',5-triiodothyronine is concentrated in and delivered from the locus coeruleus to its noradrenergic targets via anterograde axonal transport.
Gordon JT; Kaminski DM; Rozanov CB; Dratman MB
Neuroscience; 1999; 93(3):943-54. PubMed ID: 10473259
[TBL] [Abstract][Full Text] [Related]
17. Overflow of noradrenaline and dopamine in frontal cortex after [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine] (DSP-4) treatment: in vivo microdialysis study in anaesthetized rats.
Kask A; Harro J; Tuomaine P; Rägo L; Männistö PT
Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):267-72. PubMed ID: 9050022
[TBL] [Abstract][Full Text] [Related]
18. Neonatal co-lesion by DSP-4 and 5,7-DHT produces adulthood behavioral sensitization to dopamine D(2) receptor agonists.
Nowak P; Nitka D; Kwieciński A; Jośko J; Drab J; Pojda-Wilczek D; Kasperski J; Kostrzewa RM; Brus R
Pharmacol Rep; 2009; 61(2):311-8. PubMed ID: 19443944
[TBL] [Abstract][Full Text] [Related]
19. The antidepressant-like effect of vagus nerve stimulation is mediated through the locus coeruleus.
Grimonprez A; Raedt R; Portelli J; Dauwe I; Larsen LE; Bouckaert C; Delbeke J; Carrette E; Meurs A; De Herdt V; Boon P; Vonck K
J Psychiatr Res; 2015 Sep; 68():1-7. PubMed ID: 26228393
[TBL] [Abstract][Full Text] [Related]
20. Impaired exploratory behaviour after DSP-4 treatment in rats: implications for the increased anxiety after noradrenergic denervation.
Harro J; Oreland L; Vasar E; Bradwejn J
Eur Neuropsychopharmacol; 1995 Dec; 5(4):447-55. PubMed ID: 8998396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
